Real-World Experience with Dolutegravir-Based Two-Drug Regimens

Background. Dolutegravir-based 2-drug regimens (DTG 2DRs) are now accepted as alternatives to 3-drug regimens for HIV antiretroviral treatment (ART); however, literature on physician drivers for prescribing DTG 2DR is sparse. This study evaluated treatment patterns of DTG 2DR components in clinical...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	AIDS research and treatment Ročník 2020; číslo 2020; s. 1 - 8
Hlavní autoři:	Collins, Bonnie, Dominguez, Megan, Pike, James, Mrus, Joseph, Mycock, Katie, Roberts, Jenna, Waller, John, Dhir, Shelly, Garris, Cindy, Riedel, David J., Ramgopal, Moti, Ward, Douglas J., Oglesby, Alan
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	Cairo, Egypt Hindawi Publishing Corporation 2020 Hindawi John Wiley & Sons, Inc Wiley
Témata:	Age Analysis Anti-HIV agents Antiretroviral drugs Antiviral agents Atazanavir Clinical medicine Clinical Study Clinical trials Darunavir Demographics Electronic health records Highly active antiretroviral therapy HIV Human immunodeficiency virus Medical records Medical research Medicine, Experimental Patients Regulatory approval Reverse transcriptase inhibitors Studies Work experience United States > US Europe
ISSN:	2090-1240, 2090-1259
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!